Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE)
brightbox.ru

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$1.83M

About Remoto

Provider of an application that enables car remote control. The company provides an app that allows to lock and unlock doors, start the engine, heat or cool the car according to a schedule, determine the route of the vehicle, automatically notify when evacuation or impact has occurred. It displays all commands and the status of their implementation on the smartphone screen. It also alerts if the vehicle exceeds the permissible speed or leaves the designated area.

Remoto Headquarter Location

2 Ugreshskaya Street, Building 15 Business Center Synthesis, Office 28

Moscow, 115088,

Russian Federation

7 495 929 7075

Latest Remoto News

Executive Spotlight: Ken Belotsky, Partner of Negev Capital

Sep 2, 2021

Co-founder of Bright Box, the leading Connected Car technology provider, responsible for strategic decisions, fundraising and M&A. Bright Box was acquired by Zurich Insurance Group in 2018. Co-founder of BrightConsult, the top software partner of Microsoft in Eastern Europe in the Automotive industry. Company was acquired by Incadea Gmbh in 2011. As a private investor did more than 30 transactions with early- and late-stage companies in the US, Israel, and EU. Title: Partner Years at current company: 1 Most successful professional accomplishment before psychedelics: two successful exits from startups, where Ken was a co-founder, with 25x+ return for the seed investors Company Mission: Negev Capital the USD$25+ million fund is in the battle against the current Mental Health Pandemic by investing in companies that develop novel drugs for psychiatric disorders based on psychedelic compounds. Company’s most successful achievement: Over $9M USD invested in 14 companies that develop novel drugs for psychiatric disorders based on psychedelic compounds over past 6 months. Has the company raised any capital (yes or no):  Yes. If so, how much? :$20M+ USD  Any plans on raising capital in the future? We are always looking for suitable LP’s to work with on a mission to battle against the current Mental Health Pandemic. Most important company 5 year goal: We believe that psychedelic medicine will be not only disruptive to the practice of psychiatry, but hold the potential to reduce enormous amounts of human suffering, and we are committed to helping the field mature, and further promote ways for these treatments to reach all of those in need. Post Views:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.